USPTO serial 79239402
AQDROP
Reviewed by CopyMark Law Group
Reg. 5784249Status 709
- Filing date
- Status date
- Registration date
- Jun 25, 2019
- Examiner
- HUSSAIN, TASNEEM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AQDROP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments, namely, chips having microfabricated, multi-electrode arrays that can be used in chemical analysis or biological analysis | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sharp Life Science (EU) Limited
- Other trademarks owned by Sharp Life Science (EU) Limited
- Other trademarks owned by Sharp Life Science (EU) Limited
- Other trademarks in Class 009
- Similar marks named AQDROP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 9, 2026 | C71T | CANCELLED SECTION 71 | — |
| Oct 18, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 28, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 28, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 25, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 25, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2019 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 4, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 14, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 2, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 2, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 19, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 18, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 25, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 23, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |